This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/drugbank/
n12http://linked.opendata.cz/resource/mesh/concept/
n17http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
n11http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n16http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/pdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB04200/identifier/pubchem-substance/

Statements

Subject Item
n2:DB04200
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n6:DB04200 n10:DB04200
dcterms:title
Matairesinol
adms:identifier
n4:DB04200 n13:119205 n14:46507098 n15:C10682 n16:MAX n17:106491
n7:synonym
(-)-Matairesinol (alphaR,betaR)-alpha,beta-Bis(4-hydroxy-3-methoxybenzyl)butyrolactone Artigenin congener 3R,4R-Bis((4-hydroxy-3-methoxyphenyl)methyl)dihydro-2(3H)-furanone Dibenzylbutyrolactone lignanolide
n7:synthesisReference
Rainer Sjoholm, Patrik Eklund, Jyri Mikkola, Reko Lehtila, Marja Sodervale, Arja Kalapudas, "Method for the preparation of matairesinol." U.S. Patent US20050080299, issued April 14, 2005.
n11:hasConcept
n12:M0188330
n7:IUPAC-Name
n8:271B43B4-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B43BA-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B43B9-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B43B6-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B43B7-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B43B8-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B43B2-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B43B0-363D-11E5-9242-09173F13E4C5 n8:271B43B3-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B43B1-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B43C0-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B43C1-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B43BB-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B43BC-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B43BE-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B43BD-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B43BF-363D-11E5-9242-09173F13E4C5
n7:casRegistryNumber
580-72-3
n7:Bioavailability
n8:271B43C6-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B43C8-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B43C9-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B43C5-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B43C4-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B43C7-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B43B5-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B43C2-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B43C3-363D-11E5-9242-09173F13E4C5